பயோனிக்ஸ் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயோனிக்ஸ் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயோனிக்ஸ் லிமிடெட் Today - Breaking & Trending Today

This is the latest speculative ASX tech buy from Citigroup


This is the latest speculative ASX tech buy from Citigroup
Brendon Lau | January 6, 2021 10:46am |
More on:
Image source: Getty Images
If you are on the hunt for the next shooting star in the small-cap tech sector, Citigroup may have just the trick for you.
Appetite for such stocks is strong after
Brainchip Holdings Ltd(ASX: BRN) share price,
Pointerra Ltd(ASX:3DP) share price and
Tesserent Ltd(ASX: TNT) shot out the lights in 2020.
These stocks gained more than 700% over the past 12 months when the
Big rewards and risks for this ASX small cap tech stock
If you want big rewards, you have to be prepared to stomach big risks. On that front, Citigroup reckons the ....

Scott Phillips , Brainchip Holdings Ltd , Pointerra Ltd , Us Veteran Administration , National Disability Insurance Scheme , Bionics Ltd , Tesserent Ltd , Control Bionics Ltd , Control Bionics , Motley Fool Share Advisor , ஸ்காட் பிலிப்ஸ் , தேசிய இயலாமை காப்பீடு திட்டம் , பயோனிக்ஸ் லிமிடெட் , சிட்டி குழுமம் , கட்டுப்பாடு பயோனிக்ஸ் லிமிடெட் , கட்டுப்பாடு பயோனிக்ஸ் ,

Brokers name 3 ASX shares to buy right now


Citi have retained their
buy rating and $24.00 price target on this investment platform provider’s shares. The broker points out that the company has signed an agreement with
IOOF Holdings Limited (ASX: IFL). While it sees some risks from the deal, overall it views it as a positive. In addition to this, the broker believes HUB24 is well-placed to benefit from the ongoing structural shift in wealth management. The HUB24 share price is changing hands for $20.82 on Thursday.
A note out of
Morgan Stanley reveals that its analysts have retained their
overweight rating and $3.15 price target on this private health insurer’s shares. This follows the decision of the Federal Government to authorise a 3.25% increase in its premiums in 2021. It believes this is a positive for Medibank, though acknowledges that increasing premiums could lead to affordability issues for consumers. The Medibank share price is changing hands for $3.01 on Thursday afternoon. ....

Scott Phillips , Morgan Stanley , Bionics Ltd , Medibank Private Ltd , Holdings Limited , Control Bionics , Private Ltd , Federal Government , Boxing Day , Motley Fool Share Advisor , Boxing Day Sale , ஸ்காட் பிலிப்ஸ் , மோர்கன் ஸ்டான்லி , பயோனிக்ஸ் லிமிடெட் , மேடிபபங்க் ப்ரைவேட் லிமிடெட் , ஹோல்டிங்ஸ் வரையறுக்கப்பட்டவை , கட்டுப்பாடு பயோனிக்ஸ் , ப்ரைவேட் லிமிடெட் , கூட்டாட்சியின் அரசு , குத்துச்சண்டை நாள் , குத்துச்சண்டை நாள் விற்பனை ,